In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

Patients who received cilta-cel had improvements in progression-free survival and overall survival if they had sustained a minimal residual disease-negative complete response or better for at least 1 ...

Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...

Daratumumab plus VRd significantly improves survival in newly diagnosed multiple myeloma, supporting its role as a new ...